A molecular clock that reads which genes are switched on in a tissue can estimate biological age in rodents, monkeys and people, and in human blood it predicted who was more likely to die sooner.
Most aging clocks measure chemical tags on DNA and only report how old a body looks. This one is built to reflect expected mortality, so it can show whether a drug or diet that lengthens life in animals is actually slowing the damage of aging.
Geneticists Alexander Tyshkovskiy and Vadim Gladyshev at Brigham and Women's Hospital and Harvard Medical School in Boston, with colleagues in Russia, Japan and elsewhere, started with mice from the US Interventions Testing Program, which tests compounds for effects on lifespan. They sequenced RNA from the livers of 170 old mice given one of 20 treatments, including rapamycin and acarbose, and 12 young controls. They added published data to reach 4,539 rodent samples from 26 tissues, then 2,623 samples from crab-eating macaques and 4,003 from humans: 11,165 samples in all.
Separating long and short lives
Clocks trained only on calendar age barely registered treatments that extend lifespan. The mortality clocks did, and they told short-lived and long-lived animal models apart. Tissues from people with Crohn's disease, chronic kidney disease, heart failure or Alzheimer's disease looked older than expected. Turning skin cells back into stem cells made them read younger.
In blood samples from the long-running Framingham Heart Study in the United States, the clocks predicted time to death about as well as leading DNA methylation clocks. Because they are built from known genes, they also show which biological processes, such as inflammation or mitochondrial energy production, are driving a sample's age.
The human test relied on one blood cohort, and the clocks matched rather than beat the best existing tools. Like other aging clocks, they show associations and cannot by themselves prove that an intervention will extend human life.
The study was published in Nature on 27 May. The authors describe the clocks as research tools rather than clinical tests, and have released a web app and software package, free for non-commercial use, so other scientists can run them on their own data.
Sources: Mass General Brigham via EurekAlert; Nature (original study). Image: La Taupe/Wikimedia Commons (CC BY 3.0).
Comments
Please login to leave a comment Sign in